Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
PolyNovo Ltd (PNV AU)
Watchlist
128
Analysis
Health Care
•
Australia
PolyNovo Limited is a biotechnology company. The Company has a portfolio of biodegradeable polymers that have potential for application across numerous medical fields.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Quantitative Analysis
•
15 Dec 2022 15:53
ASX Short Interest Weekly (Dec 9th): QBE Insurance, Bluescope Steel, Woodside Energy, BHP, CSL
We analyzed ASX short interest report for the past week and highlight short interest changes in QBE Insurance, Bluescope Steel, Woodside Energy,...
Ke Yan, CFA, FRM
Follow
713 Views
Share
bullish
•
Omni Bridgeway
•
14 Dec 2022 05:00
S&P/ASX Index Rebalance Preview: A Busy March (Maybe January and February Too)
There could be an adhoc ASX200 inclusion in Jan. Then there could be 1 change each for the ASX20 and ASX100 indices, 4 changes for the ASX200...
Brian Freitas
Follow
1.1k Views
Share
bearish
•
Quantitative Analysis
•
11 Dec 2022 11:23
ASX Short Interest Weekly (Dec 2nd): IGO, Pilbara Mineral, Seek, Carsales.com, Allkem
We analyzed ASX short interest report for the past week and highlight short interest changes in IGO, Pilbara Mineral, Seek, Carsales.com, Allkem,...
Ke Yan, CFA, FRM
Follow
499 Views
Share
bullish
•
Monadelphous
•
02 Dec 2022 16:40
S&P ASX Dec 22 Rebalance: MND Is the Top Pick
ASX 200 ADD Monadelphous seems to be the most interesting name. There could be ~12 days of volume to buy and historically ASX 200 ADDs have...
Janaghan Jeyakumar, CFA
Follow
645 Views
Share
bullish
•
Monadelphous
•
20 Nov 2022 08:08
S&P/ASX Quiddity Final Expectations Dec 22: Mostly Mining Companies, Avoid Short Buildup!
Among the Expected DELs, St Barbara and Smartgroup have significant short buildup. The ASX 50 Expected ADDs/DELs are fairly low-impact names. But...
Janaghan Jeyakumar, CFA
Follow
670 Views
Share
First
Previous
17
18
19
20
21
22
23
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x